Kwak, Seung-Hwa and Shin, Seungheon and Lee, Ji-Hyun and Shim, Jin-Kyoung and Kim, Minjeong and Lee, So-Deok and Lee, Aram and Bae, Jinsu and Park, Jin-Hee and Abdelrahman, Aliaa and Müller, Christa E. and Cho, Steve K. and Kang, Seok-Gu and Bae, Myung Ae and Yang, Jung Yoon and Ko, Hyojin and Goddard, William A., III and Kim, Yong-Chul (2018) Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells. European Journal of Medicinal Chemistry, 151 . pp. 462-481. ISSN 0223-5234. http://resolver.caltech.edu/CaltechAUTHORS:20180410-132941529
Full text is not posted in this repository. Consult Related URLs below.
Use this Persistent URL to link to this item: http://resolver.caltech.edu/CaltechAUTHORS:20180410-132941529
Abstract
Screening a compound library of quinolinone derivatives identified compound 11a as a new P2X7 receptor antagonist. To optimize its activity, we assessed structure-activity relationships (SAR) at three different positions, R_1, R_2 and R_3, of the quinolinone scaffold. SAR analysis suggested that a carboxylic acid ethyl ester group at the R_1 position, an adamantyl carboxamide group at R_2 and a 4-methoxy substitution at the R_3 position are the best substituents for the antagonism of P2X7R activity. However, because most of the quinolinone derivatives showed low inhibitory effects in an IL-1β ELISA assay, the core structure was further modified to a quinoline skeleton with chloride or substituted phenyl groups. The optimized antagonists with the quinoline scaffold included 2-chloro-5-adamantyl-quinoline derivative (16c) and 2-(4-hydroxymethylphenyl)-5-adamantyl-quinoline derivative (17k), with IC_(50) values of 4 and 3 nM, respectively. In contrast to the quinolinone derivatives, the antagonistic effects of the quinoline compounds (16c and 17k) were paralleled by their ability to inhibit the release of the pro-inflammatory cytokine, IL-1β, from LPS/IFN-γ/BzATP-stimulated THP-1 cells (IC_(50) of 7 and 12 nM, respectively). In addition, potent P2X7R antagonists significantly inhibited the sphere size of TS15-88 glioblastoma cells.
Item Type: | Article | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Related URLs: |
| |||||||||
ORCID: |
| |||||||||
Additional Information: | © 2018 Elsevier Masson SAS. Received 21 September 2017, Revised 28 February 2018, Accepted 8 March 2018, Available online 9 March 2018. | |||||||||
Subject Keywords: | P2X7 receptor; Antagonist; IL-1β; EtBr; Inflammation; Quinoline; Quinolinone; Anti-glioma | |||||||||
Record Number: | CaltechAUTHORS:20180410-132941529 | |||||||||
Persistent URL: | http://resolver.caltech.edu/CaltechAUTHORS:20180410-132941529 | |||||||||
Official Citation: | Seung-Hwa Kwak, Seungheon Shin, Ji-Hyun Lee, Jin-Kyoung Shim, Minjeong Kim, So-Deok Lee, Aram Lee, Jinsu Bae, Jin-Hee Park, Aliaa Abdelrahman, Christa E. Müller, Steve K. Cho, Seok-Gu Kang, Myung Ae Bae, Jung Yoon Yang, Hyojin Ko, William A. Goddard, Yong-Chul Kim, Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells, European Journal of Medicinal Chemistry, Volume 151, 2018, Pages 462-481, ISSN 0223-5234, https://doi.org/10.1016/j.ejmech.2018.03.023. (http://www.sciencedirect.com/science/article/pii/S0223523418302666) | |||||||||
Usage Policy: | No commercial reproduction, distribution, display or performance rights in this work are provided. | |||||||||
ID Code: | 85728 | |||||||||
Collection: | CaltechAUTHORS | |||||||||
Deposited By: | Tony Diaz | |||||||||
Deposited On: | 11 Apr 2018 14:44 | |||||||||
Last Modified: | 11 Apr 2018 14:44 |
Repository Staff Only: item control page